CliniSys have announced that Mark Spencer has joined the company as senior vice president of global strategy.
A 25-year veteran in the life sciences and healthcare IT industry, Mark will be charged with driving growth globally.
As the world looks to improve public health now and after the pandemic, Mark will work closely with the senior leadership team to realise CliniSys‘ vision to support its customers both inside and beyond the walls of the clinical laboratory to embrace a new wave of community laboratories and digital diagnostics in healthcare, toxicology, agriculture, water and environmental testing.
“CliniSys is at an exciting stage of growth after its recent M&A activity, priming it to deliver the integrated and holistic laboratory diagnostics that will drive the next wave of innovation in disease surveillance and tracking,” said Mark.
“That is why I am looking forward to returning to the company and driving the strategies that will accelerate our growth in key regions globally.”
A former manager at Sunquest, Mark rejoins from Abbott Informatics, where he led the successful growth of its former laboratory information management system (STARLIMS). Mark began his career in the military, serving six years as a management engineer in the United States Air Force.
“Mark brings with him a deep knowledge of healthcare and technology, and a wealth of experience leading an impressive list of successful business transformations in the sector,” said CliniSys CEO Michael Simpson. “We are delighted to have him on board for this next stage in our growth.”
NHS Forth Valley goes live with RCPCH GrowthAPI integrated with Morse Mobile EPR
Mid and South Essex ICS building new shared care record with Orion Health
Red light can reduce blood glucose levels, study finds
Medical device design standards
Why rethinking funding priorities is key to virtual ward success
Thousands with cancer-causing condition offered life-saving NHS bowel cancer test
Neuromelanin imaging: A new path to brain health insights
Lenus puts automation at heart of diagnostic pathways with CDC Heart Failure roll-out
Gallery will highlight therapeutic power of art
Delays in lockdown skin cancer diagnosis linked to deaths and £6bn costs in Europe
- Insight4 weeks ago
8 tips to brand your new medical device
- Diagnostics3 weeks ago
NHS England launches gene testing programme to identify cancer risk early
- AI6 days ago
Aim AI policies at hardware to ensure safety, experts say
- Robotics4 weeks ago
Synthesis robot harnesses AI to speed up chemical discovery